“Beckman Coulter Diagnostics Joins Forces with Transformative Bio-Hermes 002 Study as New Partner”
The Future of Alzheimer’s Diagnosis: A Groundbreaking Collaboration Washington D.C., Jan. 23, 2025 (GLOBE NEWSWIRE) — The Global Alzheimer’s Platform Foundation® (GAP) has announced an exciting new partnership with Beckman Coulter Diagnostics in the Bio-Hermes-002 study. This collaboration marks a significant milestone in the field of Alzheimer’s research, as it aims to revolutionize the way…